Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Emphysema | 33 | 2024 | 688 | 3.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 52 | 2024 | 3224 | 2.660 |
Why?
|
Tomography, X-Ray Computed | 89 | 2024 | 20509 | 2.180 |
Why?
|
Lung | 50 | 2024 | 9994 | 1.510 |
Why?
|
Pulmonary Artery | 12 | 2020 | 1921 | 1.360 |
Why?
|
Image Processing, Computer-Assisted | 22 | 2020 | 8950 | 1.180 |
Why?
|
Forced Expiratory Volume | 23 | 2024 | 1809 | 1.140 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 17 | 2017 | 1215 | 1.090 |
Why?
|
Smoking | 30 | 2024 | 9073 | 1.050 |
Why?
|
Imaging, Three-Dimensional | 16 | 2020 | 4048 | 1.040 |
Why?
|
Bronchi | 4 | 2016 | 848 | 0.960 |
Why?
|
Algorithms | 28 | 2020 | 13981 | 0.950 |
Why?
|
Emphysema | 6 | 2024 | 240 | 0.870 |
Why?
|
Mucin-5B | 5 | 2018 | 147 | 0.860 |
Why?
|
Lung Diseases, Interstitial | 8 | 2023 | 911 | 0.760 |
Why?
|
Pattern Recognition, Automated | 10 | 2017 | 994 | 0.700 |
Why?
|
Bronchography | 5 | 2015 | 76 | 0.670 |
Why?
|
Pulmonary Veins | 4 | 2018 | 745 | 0.640 |
Why?
|
Bronchiectasis | 2 | 2016 | 139 | 0.620 |
Why?
|
Respiratory Function Tests | 21 | 2020 | 1683 | 0.620 |
Why?
|
Diffusion Magnetic Resonance Imaging | 6 | 2020 | 2782 | 0.540 |
Why?
|
Aortography | 2 | 2015 | 420 | 0.530 |
Why?
|
Vital Capacity | 10 | 2024 | 965 | 0.510 |
Why?
|
Spirometry | 9 | 2024 | 924 | 0.490 |
Why?
|
Software | 8 | 2020 | 4419 | 0.490 |
Why?
|
Total Lung Capacity | 8 | 2016 | 149 | 0.460 |
Why?
|
Nerve Fibers | 2 | 2008 | 708 | 0.440 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2020 | 3340 | 0.400 |
Why?
|
Aorta | 2 | 2019 | 2039 | 0.390 |
Why?
|
Severity of Illness Index | 25 | 2021 | 15840 | 0.370 |
Why?
|
Reproducibility of Results | 30 | 2017 | 20080 | 0.370 |
Why?
|
Polymorphism, Genetic | 4 | 2017 | 4291 | 0.360 |
Why?
|
Pulmonary Fibrosis | 4 | 2024 | 506 | 0.340 |
Why?
|
Ultrasonography, Interventional | 2 | 2009 | 1502 | 0.330 |
Why?
|
Calcinosis | 2 | 2015 | 1476 | 0.330 |
Why?
|
Lung Diseases | 6 | 2018 | 1915 | 0.320 |
Why?
|
Fornix, Brain | 1 | 2008 | 71 | 0.320 |
Why?
|
Surgery, Computer-Assisted | 4 | 2015 | 1008 | 0.310 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2024 | 502 | 0.310 |
Why?
|
Trachea | 3 | 2015 | 1082 | 0.310 |
Why?
|
Lung Neoplasms | 8 | 2023 | 13262 | 0.300 |
Why?
|
Laparoscopy | 3 | 2010 | 2147 | 0.300 |
Why?
|
Sensitivity and Specificity | 22 | 2017 | 14660 | 0.290 |
Why?
|
Phantoms, Imaging | 8 | 2018 | 2512 | 0.290 |
Why?
|
Pectoralis Muscles | 3 | 2021 | 85 | 0.290 |
Why?
|
Middle Aged | 75 | 2024 | 220352 | 0.280 |
Why?
|
Humans | 137 | 2024 | 760621 | 0.280 |
Why?
|
Brain Mapping | 4 | 2015 | 6568 | 0.280 |
Why?
|
Natural Orifice Endoscopic Surgery | 3 | 2013 | 119 | 0.270 |
Why?
|
Stomach | 3 | 2010 | 694 | 0.260 |
Why?
|
Radiography, Thoracic | 6 | 2014 | 1296 | 0.260 |
Why?
|
Muscular Atrophy | 2 | 2021 | 331 | 0.260 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2016 | 615 | 0.260 |
Why?
|
Male | 89 | 2024 | 359744 | 0.260 |
Why?
|
Aged | 62 | 2024 | 169152 | 0.250 |
Why?
|
alpha 1-Antitrypsin Deficiency | 2 | 2020 | 113 | 0.250 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2016 | 119 | 0.250 |
Why?
|
Heart Ventricles | 4 | 2019 | 3811 | 0.240 |
Why?
|
Pulmonary Medicine | 1 | 2007 | 221 | 0.240 |
Why?
|
Female | 86 | 2024 | 391270 | 0.220 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2007 | 867 | 0.220 |
Why?
|
Diffusion Tensor Imaging | 2 | 2017 | 2385 | 0.220 |
Why?
|
Blood Volume | 1 | 2015 | 550 | 0.220 |
Why?
|
Organ Size | 6 | 2019 | 2254 | 0.220 |
Why?
|
Caudate Nucleus | 1 | 2004 | 389 | 0.200 |
Why?
|
Schizotypal Personality Disorder | 1 | 2004 | 290 | 0.200 |
Why?
|
Mucus | 1 | 2024 | 342 | 0.200 |
Why?
|
Macrophages, Alveolar | 1 | 2024 | 409 | 0.200 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1259 | 0.200 |
Why?
|
Pneumonectomy | 4 | 2014 | 1111 | 0.200 |
Why?
|
Thorax | 2 | 2019 | 553 | 0.190 |
Why?
|
Radiographic Image Enhancement | 7 | 2016 | 875 | 0.190 |
Why?
|
Disease Progression | 9 | 2021 | 13502 | 0.190 |
Why?
|
Asthma | 5 | 2019 | 6172 | 0.190 |
Why?
|
Models, Statistical | 3 | 2015 | 5075 | 0.180 |
Why?
|
Anisotropy | 3 | 2012 | 1278 | 0.180 |
Why?
|
User-Computer Interface | 5 | 2016 | 1403 | 0.180 |
Why?
|
Blood Vessels | 2 | 2018 | 1112 | 0.180 |
Why?
|
Early Detection of Cancer | 3 | 2023 | 3202 | 0.180 |
Why?
|
Principal Component Analysis | 2 | 2013 | 940 | 0.170 |
Why?
|
Echo-Planar Imaging | 1 | 2004 | 657 | 0.170 |
Why?
|
Hypertension, Pulmonary | 3 | 2015 | 1570 | 0.170 |
Why?
|
Respiratory Mechanics | 3 | 2013 | 699 | 0.170 |
Why?
|
Endoscopy | 1 | 2009 | 1838 | 0.160 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 822 | 0.160 |
Why?
|
Discriminant Analysis | 2 | 2014 | 223 | 0.160 |
Why?
|
Logistic Models | 10 | 2020 | 13314 | 0.160 |
Why?
|
Arthritis, Rheumatoid | 2 | 2024 | 3763 | 0.150 |
Why?
|
Drug Design | 1 | 2013 | 1061 | 0.150 |
Why?
|
Databases as Topic | 1 | 2020 | 474 | 0.150 |
Why?
|
Radiation Dosage | 3 | 2017 | 1958 | 0.150 |
Why?
|
Observer Variation | 5 | 2017 | 2601 | 0.150 |
Why?
|
Airway Remodeling | 4 | 2017 | 134 | 0.150 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 469 | 0.150 |
Why?
|
Pulmonary Ventilation | 2 | 2009 | 371 | 0.140 |
Why?
|
Computer Simulation | 4 | 2015 | 6218 | 0.140 |
Why?
|
Longitudinal Studies | 10 | 2024 | 14495 | 0.140 |
Why?
|
Bronchial Arteries | 1 | 2016 | 21 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 10 | 2018 | 36290 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 7 | 2019 | 17790 | 0.140 |
Why?
|
Leukocyte Count | 1 | 2021 | 1600 | 0.140 |
Why?
|
Regression Analysis | 6 | 2016 | 6360 | 0.140 |
Why?
|
Cohort Studies | 17 | 2023 | 41335 | 0.140 |
Why?
|
Cardiac Volume | 1 | 2017 | 199 | 0.130 |
Why?
|
Data Interpretation, Statistical | 2 | 2015 | 2696 | 0.130 |
Why?
|
Bronchiolitis Obliterans | 1 | 2017 | 213 | 0.130 |
Why?
|
Endosonography | 2 | 2011 | 607 | 0.120 |
Why?
|
Aortic Diseases | 2 | 2012 | 736 | 0.120 |
Why?
|
Ventricular Function | 1 | 2017 | 408 | 0.120 |
Why?
|
Ultrasonography | 3 | 2008 | 5961 | 0.120 |
Why?
|
Neural Pathways | 1 | 2006 | 3040 | 0.120 |
Why?
|
Adaptive Immunity | 1 | 2019 | 726 | 0.120 |
Why?
|
Lung Injury | 1 | 2019 | 424 | 0.120 |
Why?
|
Heart | 1 | 2017 | 4393 | 0.120 |
Why?
|
Artificial Intelligence | 2 | 2006 | 2557 | 0.120 |
Why?
|
Comorbidity | 7 | 2020 | 10551 | 0.120 |
Why?
|
Respiratory Sounds | 1 | 2018 | 697 | 0.110 |
Why?
|
Calibration | 3 | 2017 | 816 | 0.110 |
Why?
|
Respiratory Muscles | 1 | 2014 | 142 | 0.110 |
Why?
|
ROC Curve | 3 | 2017 | 3568 | 0.110 |
Why?
|
Diagnostic Imaging | 3 | 2019 | 3527 | 0.110 |
Why?
|
Promoter Regions, Genetic | 4 | 2018 | 5785 | 0.110 |
Why?
|
Lateral Ventricles | 1 | 2015 | 146 | 0.110 |
Why?
|
Matrix Metalloproteinases | 1 | 2016 | 392 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1374 | 0.110 |
Why?
|
Image Enhancement | 3 | 2007 | 2881 | 0.110 |
Why?
|
DNA | 2 | 2018 | 7233 | 0.110 |
Why?
|
Exercise Tolerance | 3 | 2022 | 830 | 0.110 |
Why?
|
Ventriculostomy | 1 | 2015 | 131 | 0.110 |
Why?
|
Neuronavigation | 1 | 2015 | 164 | 0.110 |
Why?
|
Proteomics | 2 | 2024 | 3817 | 0.110 |
Why?
|
Cause of Death | 3 | 2024 | 3725 | 0.110 |
Why?
|
Inhalation | 1 | 2013 | 143 | 0.110 |
Why?
|
Mediastinoscopy | 1 | 2013 | 29 | 0.110 |
Why?
|
Vehicle Emissions | 1 | 2018 | 653 | 0.110 |
Why?
|
Automation | 1 | 2015 | 580 | 0.110 |
Why?
|
Radiology | 1 | 2007 | 2102 | 0.110 |
Why?
|
Brain Neoplasms | 2 | 2020 | 8986 | 0.110 |
Why?
|
Exhalation | 1 | 2013 | 181 | 0.110 |
Why?
|
Swine | 5 | 2015 | 5899 | 0.100 |
Why?
|
Analysis of Variance | 5 | 2016 | 6238 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1636 | 0.100 |
Why?
|
Aged, 80 and over | 16 | 2020 | 58995 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 748 | 0.100 |
Why?
|
Pulmonary Embolism | 2 | 2016 | 2543 | 0.100 |
Why?
|
Biomedical Research | 1 | 2017 | 3426 | 0.100 |
Why?
|
Preoperative Period | 1 | 2014 | 555 | 0.100 |
Why?
|
Predictive Value of Tests | 10 | 2021 | 15289 | 0.100 |
Why?
|
Catheters | 1 | 2015 | 425 | 0.100 |
Why?
|
Genome-Wide Association Study | 5 | 2019 | 12626 | 0.100 |
Why?
|
Motor Activity | 2 | 2016 | 2687 | 0.100 |
Why?
|
Colonoscopes | 1 | 2010 | 17 | 0.090 |
Why?
|
Oxygen Consumption | 2 | 2022 | 1843 | 0.090 |
Why?
|
Pneumothorax | 1 | 2014 | 379 | 0.090 |
Why?
|
Normal Distribution | 3 | 2011 | 273 | 0.090 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 393 | 0.090 |
Why?
|
Fibrinogen | 1 | 2014 | 886 | 0.090 |
Why?
|
Prospective Studies | 12 | 2024 | 54303 | 0.090 |
Why?
|
Computer Systems | 1 | 2012 | 470 | 0.090 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1736 | 0.090 |
Why?
|
Skull | 1 | 2015 | 815 | 0.090 |
Why?
|
Body Mass Index | 6 | 2021 | 12914 | 0.090 |
Why?
|
Multivariate Analysis | 8 | 2016 | 12159 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2608 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2018 | 15789 | 0.090 |
Why?
|
Schizophrenia | 1 | 2008 | 6915 | 0.090 |
Why?
|
Densitometry | 1 | 2010 | 151 | 0.090 |
Why?
|
Brain Diseases | 2 | 2015 | 1540 | 0.090 |
Why?
|
Functional Laterality | 2 | 2008 | 2253 | 0.080 |
Why?
|
Genetic Loci | 2 | 2020 | 2618 | 0.080 |
Why?
|
Adult | 22 | 2024 | 219994 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2019 | 22053 | 0.080 |
Why?
|
Genotype | 4 | 2020 | 12960 | 0.080 |
Why?
|
Prognosis | 11 | 2021 | 29658 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2016 | 2135 | 0.080 |
Why?
|
Pancreatic Diseases | 1 | 2011 | 343 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2024 | 748 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15757 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1846 | 0.080 |
Why?
|
Artifacts | 1 | 2017 | 1898 | 0.080 |
Why?
|
Statistics as Topic | 4 | 2011 | 2362 | 0.080 |
Why?
|
Hydrocephalus | 1 | 2015 | 763 | 0.080 |
Why?
|
Prevalence | 7 | 2023 | 15687 | 0.080 |
Why?
|
Dyspnea | 3 | 2013 | 1352 | 0.070 |
Why?
|
Computer Graphics | 1 | 2009 | 341 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2017 | 1305 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2021 | 3839 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 5251 | 0.070 |
Why?
|
Linear Models | 5 | 2017 | 5877 | 0.070 |
Why?
|
Quality of Life | 5 | 2021 | 13308 | 0.070 |
Why?
|
Inflammasomes | 1 | 2012 | 530 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2709 | 0.070 |
Why?
|
Particulate Matter | 1 | 2018 | 2559 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6315 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4742 | 0.070 |
Why?
|
Cognition | 1 | 2004 | 6957 | 0.070 |
Why?
|
Arteriosclerosis | 1 | 2010 | 1064 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1204 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2017 | 3301 | 0.060 |
Why?
|
Retrospective Studies | 12 | 2024 | 80372 | 0.060 |
Why?
|
Airway Resistance | 1 | 2016 | 400 | 0.060 |
Why?
|
Abdominal Injuries | 1 | 2008 | 359 | 0.060 |
Why?
|
Body Composition | 3 | 2021 | 2419 | 0.060 |
Why?
|
Abdomen | 1 | 2010 | 1130 | 0.060 |
Why?
|
Adiposity | 1 | 2014 | 1858 | 0.060 |
Why?
|
Air Pollution | 1 | 2018 | 2317 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2809 | 0.060 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 393 | 0.060 |
Why?
|
Hemodynamics | 1 | 2014 | 4174 | 0.060 |
Why?
|
Monocytes | 2 | 2024 | 2575 | 0.060 |
Why?
|
Neuropsychological Tests | 2 | 2008 | 7021 | 0.050 |
Why?
|
Models, Biological | 2 | 2016 | 9467 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2017 | 15697 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2018 | 4412 | 0.050 |
Why?
|
Airway Obstruction | 3 | 2016 | 662 | 0.050 |
Why?
|
Risk Factors | 11 | 2018 | 74359 | 0.050 |
Why?
|
Subtraction Technique | 1 | 2006 | 510 | 0.050 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2008 | 707 | 0.050 |
Why?
|
Colonoscopy | 1 | 2010 | 1387 | 0.050 |
Why?
|
Survival Rate | 4 | 2018 | 12808 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2015 | 4938 | 0.050 |
Why?
|
Mental Recall | 1 | 2008 | 1206 | 0.050 |
Why?
|
Tomography, Spiral Computed | 2 | 2014 | 273 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2016 | 2859 | 0.050 |
Why?
|
Lung Volume Measurements | 2 | 2015 | 376 | 0.050 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 2013 | 94 | 0.050 |
Why?
|
Respiration, Artificial | 2 | 2019 | 2622 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2024 | 605 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3531 | 0.050 |
Why?
|
Risk Assessment | 8 | 2018 | 24123 | 0.050 |
Why?
|
Memory Disorders | 1 | 2008 | 1197 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2016 | 12531 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39261 | 0.050 |
Why?
|
United States | 9 | 2021 | 72461 | 0.050 |
Why?
|
Residual Volume | 2 | 2011 | 41 | 0.050 |
Why?
|
Classification | 1 | 2021 | 127 | 0.050 |
Why?
|
Electromagnetic Phenomena | 2 | 2015 | 161 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10790 | 0.050 |
Why?
|
Sex Distribution | 2 | 2014 | 2295 | 0.050 |
Why?
|
Radiography | 2 | 2016 | 6965 | 0.040 |
Why?
|
Internationality | 2 | 2017 | 1004 | 0.040 |
Why?
|
Visual Perception | 1 | 2008 | 1374 | 0.040 |
Why?
|
Exercise Test | 2 | 2022 | 2128 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 25942 | 0.040 |
Why?
|
Cicatrix | 1 | 2006 | 782 | 0.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 1046 | 0.040 |
Why?
|
alpha 1-Antitrypsin | 1 | 2020 | 169 | 0.040 |
Why?
|
Endoderm | 1 | 2020 | 160 | 0.040 |
Why?
|
APACHE | 1 | 2019 | 267 | 0.040 |
Why?
|
Organ Specificity | 1 | 2014 | 1955 | 0.040 |
Why?
|
Brain | 5 | 2018 | 26951 | 0.040 |
Why?
|
Angiography | 2 | 2015 | 1605 | 0.040 |
Why?
|
Respiration | 1 | 2015 | 1654 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2013 | 805 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2209 | 0.040 |
Why?
|
Animals | 8 | 2016 | 167963 | 0.040 |
Why?
|
Tidal Volume | 2 | 2011 | 487 | 0.040 |
Why?
|
Oxygen | 2 | 2022 | 4193 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21025 | 0.040 |
Why?
|
Alabama | 1 | 2007 | 104 | 0.040 |
Why?
|
Iceland | 1 | 2017 | 184 | 0.040 |
Why?
|
Reaction Time | 1 | 2004 | 2075 | 0.040 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2007 | 119 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3334 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16546 | 0.030 |
Why?
|
Sex Factors | 3 | 2014 | 10547 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 8035 | 0.030 |
Why?
|
Contrast Media | 3 | 2014 | 5305 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2016 | 151 | 0.030 |
Why?
|
Iron Regulatory Protein 2 | 1 | 2015 | 42 | 0.030 |
Why?
|
Odds Ratio | 2 | 2018 | 9716 | 0.030 |
Why?
|
Denmark | 1 | 2018 | 760 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3618 | 0.030 |
Why?
|
Internet | 1 | 2017 | 3078 | 0.030 |
Why?
|
Maximal Midexpiratory Flow Rate | 1 | 2015 | 76 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2008 | 3061 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 471 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8158 | 0.030 |
Why?
|
Clinical Competence | 1 | 2010 | 4783 | 0.030 |
Why?
|
Equipment Design | 2 | 2015 | 3520 | 0.030 |
Why?
|
Internship and Residency | 2 | 2015 | 5870 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3465 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 10182 | 0.030 |
Why?
|
Diffusion | 1 | 2006 | 813 | 0.030 |
Why?
|
Computer-Aided Design | 1 | 2016 | 302 | 0.030 |
Why?
|
Serpins | 1 | 2015 | 247 | 0.030 |
Why?
|
Boston | 2 | 2017 | 9280 | 0.030 |
Why?
|
Fiducial Markers | 1 | 2015 | 132 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2015 | 3112 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2004 | 6015 | 0.030 |
Why?
|
Oximetry | 1 | 2016 | 461 | 0.030 |
Why?
|
Electric Impedance | 1 | 2017 | 755 | 0.030 |
Why?
|
Evoked Potentials, Visual | 1 | 2006 | 415 | 0.030 |
Why?
|
Young Adult | 5 | 2018 | 58741 | 0.030 |
Why?
|
Hepatocytes | 1 | 2020 | 1229 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8803 | 0.030 |
Why?
|
Lymphocytes | 1 | 2021 | 2611 | 0.030 |
Why?
|
Quality Control | 1 | 2006 | 828 | 0.030 |
Why?
|
Spain | 1 | 2014 | 488 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2698 | 0.030 |
Why?
|
Health Policy | 1 | 2015 | 2677 | 0.030 |
Why?
|
Models, Animal | 2 | 2010 | 2117 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2015 | 475 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 11847 | 0.030 |
Why?
|
Bronchospirometry | 1 | 2011 | 10 | 0.030 |
Why?
|
Receptors, Nicotinic | 1 | 2015 | 494 | 0.030 |
Why?
|
Rest | 1 | 2016 | 914 | 0.020 |
Why?
|
Digestive System | 1 | 2012 | 244 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2016 | 594 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2014 | 743 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2014 | 409 | 0.020 |
Why?
|
Pelvic Floor | 1 | 2012 | 138 | 0.020 |
Why?
|
Cell Lineage | 1 | 2020 | 2533 | 0.020 |
Why?
|
Caspase 1 | 1 | 2012 | 226 | 0.020 |
Why?
|
Abdominal Wall | 1 | 2012 | 165 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1630 | 0.020 |
Why?
|
Bleomycin | 1 | 2012 | 495 | 0.020 |
Why?
|
Bronchioles | 1 | 2010 | 30 | 0.020 |
Why?
|
Stroke Volume | 2 | 2017 | 5523 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2016 | 911 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 379 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2013 | 653 | 0.020 |
Why?
|
Incidence | 3 | 2017 | 21392 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2781 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2004 | 3976 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2213 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7343 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2006 | 978 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1826 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2009 | 273 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9631 | 0.020 |
Why?
|
Genetic Markers | 1 | 2015 | 2608 | 0.020 |
Why?
|
Health Services | 1 | 2013 | 753 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2011 | 351 | 0.020 |
Why?
|
Motor Cortex | 1 | 2006 | 995 | 0.020 |
Why?
|
Visual Cortex | 1 | 2006 | 1089 | 0.020 |
Why?
|
Neurosurgery | 1 | 2015 | 670 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3767 | 0.020 |
Why?
|
Cadaver | 1 | 2012 | 1345 | 0.020 |
Why?
|
Respiratory System | 1 | 2011 | 557 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9411 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1754 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3301 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2010 | 532 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7269 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5423 | 0.020 |
Why?
|
Motion | 1 | 2010 | 779 | 0.020 |
Why?
|
Esophagus | 1 | 2013 | 1023 | 0.020 |
Why?
|
Surface Properties | 1 | 2009 | 1161 | 0.020 |
Why?
|
Sample Size | 1 | 2009 | 840 | 0.020 |
Why?
|
Pilot Projects | 2 | 2011 | 8555 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4625 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6898 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6479 | 0.020 |
Why?
|
Rectum | 1 | 2010 | 895 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6828 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5425 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6544 | 0.020 |
Why?
|
Particle Size | 1 | 2009 | 1644 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2802 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3707 | 0.010 |
Why?
|
Echocardiography | 1 | 2017 | 4981 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2629 | 0.010 |
Why?
|
Models, Anatomic | 1 | 2007 | 682 | 0.010 |
Why?
|
Stents | 1 | 2016 | 3314 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2475 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6414 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11481 | 0.010 |
Why?
|
Walking | 1 | 2010 | 1189 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 4407 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11071 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8469 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 87810 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5201 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18416 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36060 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65017 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6659 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 29932 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22023 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 22072 | 0.000 |
Why?
|
Child | 1 | 2014 | 79806 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81208 | 0.000 |
Why?
|